These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9312623)

  • 1. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].
    Högestätt ED; Andersson KE
    Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-channel drugs: structure-function relationships and selectivity of action.
    Triggle DJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S1-6. PubMed ID: 1724996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental pharmacology of calcium antagonists].
    Godfraind T
    Therapie; 1993; 48 Spec No():637-49. PubMed ID: 8091349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ; Swamy VC
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do calcium antagonists differ in clinical practice?
    Ferrari R; Cucchini F; Bolognesi R; Bachetti T; Boraso A; Bernocchi P; Gaia G; Visioli O
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():565-75. PubMed ID: 7841090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification and tissue selectivity of calcium antagonists.
    Nayler WG
    Z Kardiol; 1990; 79 Suppl 3():107-11. PubMed ID: 1965934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New findings on calcium antagonism].
    Ferrari R; Ceconi C; Curello S; Visioli O
    Ann Ital Med Int; 1992; 7(3 Suppl):100S-111S. PubMed ID: 1338419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].
    Takahara A
    Clin Calcium; 2010 Jan; 20(1):24-30. PubMed ID: 20048430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists].
    Adachi-Akahane S
    Clin Calcium; 2005 Oct; 15(10):1589-97. PubMed ID: 16199903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists. Pharmacologic differences and similarities.
    Wood AJ
    Circulation; 1989 Dec; 80(6 Suppl):IV184-8. PubMed ID: 2598454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.
    Hu H; Marban E
    Mol Pharmacol; 1998 May; 53(5):902-7. PubMed ID: 9584217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium entry blocking drugs: their classification and sites of action in smooth muscle cells.
    Raeburn D
    Med Biol; 1987; 65(4):175-80. PubMed ID: 3325698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of calcium entry blockers.
    Godfraind T
    Fed Proc; 1981 Dec; 40(14):2866-71. PubMed ID: 7308497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium channels and calcium antagonists].
    Imai S
    Tanpakushitsu Kakusan Koso; 1988 Sep; 33(12):1862-76. PubMed ID: 2855995
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors modifying the tissue selectivity of calcium-antagonists.
    Spedding M; Fraser S; Clarke B; Patmore L
    J Neural Transm Suppl; 1990; 31():5-16. PubMed ID: 1963634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.